Ryuichi Kamiyama
Ryuichi Kamiyama publishes mostly in Hematology, Molecular Biology and Oncology, on topics such as Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment and Chronic Lymphocytic Leukemia Research.
- World rank
- #5,826,059 of 7,710,434 ranked researchers
- Rank in Japan
- #210,036 of 383,136
- Works
- 110
- Citations
- 2.2k
- Citations per work
- 20.5
What does Ryuichi Kamiyama research?
Ryuichi Kamiyama's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5045.3%
- Medicine5045.3%
- Everything else4944.4%
- Life Sciences1110.3%
- 1Hematology13% of their works
- 2Molecular Biology10% of their works
- 3Oncology9% of their works
- 4Pathology and Forensic Medicine9% of their works
- 5Genetics8% of their works
- 6Pulmonary and Respiratory Medicine6% of their works
Research topics
- Acute Myeloid Leukemia Research
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Hematological disorders and diagnostics
- Cytokine Signaling Pathways and Interactions
- Retinoids in leukemia and cellular processes
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Genetic factors in colorectal cancer
Which keywords describe Ryuichi Kamiyama's research?
The keywords of their largest research topics: Prognostic Factors, Rituximab, Acute Myeloid Leukemia, AML, Inflammation, Classification, Lymphoma and Chronic Lymphocytic Leukemia.
- Molecular Characterization
- JAK2 Mutation
- Acute Promyelocytic Leukemia
- IL-6
- Bone Marrow Biopsy
- Chronic Lymphocytic Leukemia
- Classification
- Acute Myeloid Leukemia
- Rituximab
- Prognostic Factors
- AML
- Inflammation
- Lymphoma
- Genomic Aberrations
- FDG PET/CT
- STAT3
- Retinoic Acid
- Microsatellite Instability
- Myelofibrosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Prognostic Factors382 topics
- Rituximab272 topics
- AML261 topic
- Acute Myeloid Leukemia261 topic
- Inflammation192 topics
- Classification151 topic
- Lymphoma151 topic
- Chronic Lymphocytic Leukemia121 topic
- Genomic Aberrations121 topic
- Bone Marrow Biopsy101 topic
- FDG PET/CT101 topic
- IL-691 topic
- STAT391 topic
- Acute Promyelocytic Leukemia81 topic
- Retinoic Acid81 topic
- JAK2 Mutation71 topic
- Microsatellite Instability71 topic
- Molecular Characterization71 topic
- Myelofibrosis71 topic
Where does Ryuichi Kamiyama work?
Ryuichi Kamiyama's main affiliation in the publication record is Tokyo Medical and Dental University, Japan.
How many publications and citations does Ryuichi Kamiyama have?
OpenAlex counts 110 works and 2,250 citations for Ryuichi Kamiyama, an h-index of 26, ranking #5,826,059 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ryuichi Kamiyama. Posts are plain text and can be reported.